Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism.
Hichem Miraoui, Andrew A Dwyer, Gerasimos P Sykiotis...
https://pubmed.ncbi.nlm.nih.gov/23643382Actively Recruiting
Led by Centre Hospitalier Universitaire Vaudois · Updated on 2022-06-21
2000
Participants Needed
1
Research Sites
260 weeks
Total Duration
C
Centre Hospitalier Universitaire Vaudois
Lead Sponsor
S
Swiss National Science Foundation
Collaborating Sponsor
Researchers are investigating the genetic causes of reproductive disorders such as hypogonadotropic hypogonadism and Kallmann syndrome, as well as cleft lip and/or palate. These conditions affect puberty, sexual maturation, and fertility, and may share genetic links. The study aims to deepen understanding of the genetic control of puberty and reproduction, and how these relate to cleft lip and palate, with hopes to improve diagnosis, treatment, and counseling for affected individuals and families. Participants with reproductive disorders, with or without cleft lip/palate, and their family members will be enrolled. Patients will complete medical questionnaires, provide family history, and have various specimens collected including blood, saliva, urine, hair follicles, sperm, or skin biopsies. They will also undergo tests such as smell and hearing assessments, bone density scans, brain MRI, and ultrasounds of kidney and reproductive organs. Family members will also provide questionnaires, samples, and undergo smell testing. During the study, researchers will analyze genetic variants and their function, inheritance patterns, and how these relate to physical traits. The main outcome is identifying rare genetic sequence variants. Participants will be monitored for about one year following variant identification. The study includes ongoing assessments of family history, clinical features, and biological samples to better understand these inherited conditions and their impact.
CONDITIONS
Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants complete medical questionnaires, family history review, and undergo various tests including smell testing, hearing test, bone density, brain MRI, and ultrasound as applicable.
1 to 2 visits depending on assessments
Duration - Up to 1 year or ongoing if no variants are identified
Participants are monitored for genetic findings and follow-up studies related to rare sequence variants and their impact on reproductive disorders and cleft lip/palate.
Periodic visits depending on variant identification and follow-up needs
Total: 1 location
1
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Canton of Vaud, Switzerland, 1011
Actively Recruiting
E
Emmanuelle Paccou
M
Michela Adamo, MD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hichem Miraoui, Andrew A Dwyer, Gerasimos P Sykiotis...
https://pubmed.ncbi.nlm.nih.gov/23643382Carine Villanueva, Elka Jacobson-Dickman, Cheng Xu...
https://pubmed.ncbi.nlm.nih.gov/25394172